Amos Matsiko

Dr. Amos Matsiko


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Acta Biomaterialia
Verified
Journal Article
Closed access
Tanya J. LevingstoneTanya J. Levingstone
Tanya J. Levingstone
AMAmos Matsiko
Amos Matsiko
GDGlenn R. Dickson
Glenn R. Dickson
Fergal O'BrienFergal O'Brien
Fergal O'Brien
JGJohn P. Gleeson
John P. Gleeson

1 February 2015 in Tissue Engineering Part A
Verified
Journal Article
Closed access
AMAmos Matsiko
Amos Matsiko
JGJohn P. Gleeson
John P. Gleeson
Fergal O'BrienFergal O'Brien
Fergal O'Brien
Recent investigations into micro-architecture of scaffolds has revealed that mean pore sizes are cell-type specific and influence cellular shape, differentiation, and extracellular matrix secretion. In this context, the overall goal of this study was to investigate whether scaffold mean pore sizes affect mesenchymal stem cell initial attachment, chondrogenic gene expression, and cartilage-like matrix deposition. Collagen-hyaluronic acid (CHyA) scaffolds, recently developed in our laboratory for in vitro chondrogenesis, were fabricated with three distinct mean pore sizes (94, 130, and 300 μm) by altering the freeze-drying technique used. It was evident that scaffolds with the largest mean pore sizes (300 μm) stimulated significantly higher cell proliferation, chondrogenic gene expression, cartilage-like matrix deposition, and resulting bulk compressive modulus after in vitro culture, relative to scaffolds with smaller mean pore sizes (94, 130 μm). Taken together, these findings demonstrate the importance of scaffold micro-architecture in the development of advanced tissue engineering strategies for articular cartilage defect repair.

1 July 2012 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
Ciara MurphyCiara Murphy
Ciara Murphy
AMAmos Matsiko
Amos Matsiko
MHMatthew G. Haugh
Matthew G. Haugh
JGJohn P. Gleeson
John P. Gleeson
FOFergal J. O’bRien
Fergal J. O’bRien

11 June 2014 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
ETEmmet M. Thompson
Emmet M. Thompson
AMAmos Matsiko
Amos Matsiko
EFEric Farrell
Eric Farrell
DKDaniel Kelly
Daniel Kelly
Fergal O'BrienFergal O'Brien
Fergal O'Brien

1 July 2012 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
AMAmos Matsiko
Amos Matsiko
Tanya J. LevingstoneTanya J. Levingstone
Tanya J. Levingstone
FOFergal J. O’bRien
Fergal J. O’bRien
JGJohn P. Gleeson
John P. Gleeson

22 February 2013 in Materials
Verified
Journal Article
Open access
PDF file
AMAmos Matsiko
Amos Matsiko
Tanya J. LevingstoneTanya J. Levingstone
Tanya J. Levingstone
Fergal O'BrienFergal O'Brien
Fergal O'Brien
Articular cartilage is a unique tissue owing to its ability to withstand repetitive compressive stress throughout an individual’s lifetime. However, its major limitation is the inability to heal even the most minor injuries. There still remains an inherent lack of strategies that stimulate hyaline-like articular cartilage growth with appropriate functional properties. Recent scientific advances in tissue engineering have made significant steps towards development of constructs for articular cartilage repair. In particular, research has shown the potential of biomaterial physico-chemical properties significantly influencing the proliferation, differentiation and matrix deposition by progenitor cells. Accordingly, this highlights the potential of using such properties to direct the lineage towards which such cells follow. Moreover, the use of soluble growth factors to enhance the bioactivity and regenerative capacity of biomaterials has recently been adopted by researchers in the field of tissue engineering. In addition, gene therapy is a growing area that has found noteworthy use in tissue engineering partly due to the potential to overcome some drawbacks associated with current growth factor delivery systems. In this context, such advanced strategies in biomaterial science, cell-based and growth factor-based therapies that have been employed in the restoration and repair of damaged articular cartilage will be the focus of this review article.